These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3288431)

  • 1. Discrepancy between first-dose converting enzyme inhibition at rest and subsequent inhibition during exercise in chronic heart failure.
    Kirlin PC; Dansby C; Laird CK; Willis PW
    Clin Pharmacol Ther; 1988 Jun; 43(6):616-22. PubMed ID: 3288431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal and renal responses to converting enzyme inhibition during maximal exercise.
    Wade CE; Ramee SR; Hunt MM; White CJ
    J Appl Physiol (1985); 1987 Nov; 63(5):1796-800. PubMed ID: 2826383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans.
    Fagard R; Lijnen P; Vanhees L; Amery A
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Sep; 53(3):576-81. PubMed ID: 6290435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
    Packer M; Medina N; Yushak M; Lee WH
    Br Heart J; 1985 Sep; 54(3):298-304. PubMed ID: 2994697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.
    Insel J; Mirvis DM; Boland MJ; Cinquegrani MP; Shanes J; Rubin SA; Whalen JJ
    Clin Pharmacol Ther; 1989 Mar; 45(3):312-20. PubMed ID: 2537699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
    Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
    Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosenopril, an angiotensin-converting enzyme inhibitor, and propranolol: comparative effects at rest and exercise on blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA; Cervenka J; O'Connor DT; Dineen M
    Cardiovasc Drugs Ther; 1989 Mar; 3(1):57-62. PubMed ID: 2535052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oral converting enzyme inhibitor SQ 14225 in experimental high output failure.
    Williams GM; Davis JO; Freeman RH; DeForrest JM; Seymour AA; Rowe BP
    Am J Physiol; 1979 Jun; 236(6):F541-5. PubMed ID: 220888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.
    MacDonald NJ; Hughes DM; Lees KR; Reid JL
    Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension.
    Sullivan PA; Dineen M; Cervenka J; O'Connor DT
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):280S-283S. PubMed ID: 2970855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.